BSE filing, NSE: PRASOLCHEM. Summary written from the filing by ALFA Finder's alert engine.
Prasol Chemicals Ltd: key numbers
- Share price
- ₹817.25
- Market cap
- ₹4,837 Cr
- Revenue (annual)
- ₹1,233 Cr
- Net profit (annual)
- ₹83.12 Cr
- Promoter holding
- 75.25%
- FII holding
- 0.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Prasol Chemicals Ltd
All →Prasol Chemicals Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs412.6cr (+38.6% YoY), PAT Rs37.9cr (+122.2%), EBITDA margin 14.0%. H1 FY27 revenue Rs846.2cr (+37.1%), highest-ever Q2.
Prasol Chemicals Q2 FY27 Results: Net Profit ₹38 Cr, Up 122.2% YoY
Prasol Chemicals Ltd reported revenue from operations of ₹412.6 Cr (+38.6% YoY) and net profit of ₹38 Cr (+122.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹38 Cr · +122.2% YoY
Prasol Chemicals Other Announcement
Prasol Chemicals Ltd has filed its shareholding pattern for the quarter ended September 30, 2026, as per regulatory requirements.
Prasol Chemicals Other Announcement
Prasol Chemicals Limited updated its Corporate Identification Number (CIN) from "U99999MH1992PLC065026" to "L99999MH1992PLC065026" following its recent equity listing.
Prasol Chemicals Earnings Call Transcript: Key Takeaways
Prasol Chemicals reported record Q1 FY27 performance with revenue up 36% YoY. Strategy focuses on expanding high-margin acetone and phosphorus derivatives via massive capex and R&D.
- Call
- Guides 26% growth
Prasol Chemicals Investor Presentation: Key Takeaways
Prasol Chemicals reported record Q1FY27 performance following its Sep 2026 IPO, driven by volume growth and improved product mix in Acetone and Phosphorus derivatives.
- Call
- Guides 143% growth
Other board meeting date announcements
All →Olympic Cards Board Meeting Date
Olympic Cards schedules a board meeting on 12 November 2026 to consider unaudited quarterly results. The trading window stays closed until results are declared.
Vaishali Pharma Board Meeting Date
Vaishali Pharma has scheduled an audit committee meeting for 5 November 2026. Proposed agenda includes a fund raise via preferential issue and an increase in authorised capital.
Ventura Textiles Board Meeting Date
Ventura Textiles scheduled a board meeting for 9 November 2026 to consider unaudited results and new business strategy. The agenda is proposed until the meeting is held.
Sampre Nutritions Board Meeting Date
Sampre Nutritions has scheduled a board meeting on 6 November 2026 to consider its unaudited Q2 FY27 standalone and consolidated results. The filing is an advance notice with no results figures yet disclosed.
National General Industries Board Meeting Date
National General Industries will hold a board meeting on November 10, 2026 to consider unaudited quarterly results. Trading window stays closed until November 16, 2026.
Vision Cinemas Board Meeting Date
Vision Cinemas Limited has intimated a board meeting on 10 November 2026 to consider unaudited standalone and consolidated half-yearly results for the period ended September 2026. The trading window is closed from 1 October 2026 until 48 hours after results declaration.